Medicare drug negotiations

Political tensions escalate as drug pricing bills move forward
Rift began when Pelosi called for Medicare to negotiate prices for a set of high-cost drugs

Senate Finance Chairman Charles E. Grassley, R-Iowa unveiled the text of his committee's drug pricing bill on Wednesday. (Caroline Brehman/CQ Roll Call file photo)

The discord between the parties over plans to bring down drug costs deepened this week as Democrats insisted on allowing Medicare to negotiate prices and launched an impeachment inquiry that threatens to consume Congress.

Still, members of key committees said Wednesday they wanted to continue bipartisan work to lower costs, a major concern of voters, and lawmakers in both chambers took steps toward advancing their proposals. The House Energy and Commerce Health Subcommittee held the first hearing on legislation unveiled last week by House Speaker Nancy Pelosi, D-California, and Democrats leaving a caucus meeting on drug legislation late Wednesday said markups are expected soon after a two-week recess in October. Meanwhile, Senate Finance Chairman Charles E. Grassley, R-Iowa and ranking Democrat Ron Wyden of Oregon unveiled the text of their bill on Wednesday.